|
by Molly M. Ginty
Whatever stage of life you’re in, and whether
you’re physically fit or living with chronic
illness, you can find ways to be a wise steward of
your health and well-being. Our health and wholeness
are important keys to responding to God’s call for
us and acting boldly on that call. That’s why Women
of the ELCA have embarked on a new
health initiative: Raising up Healthy
Women and Girls. This ongoing column represents our
commitment to the issue of women’s health.
The news rattled
Marilyn Kentz even more than the hot flashes and
mood swings she suffered.
"When a 2002 study found that the drugs I was
taking for menopause could increase the risk of
heart attack, I was shocked and terrified," says
Kentz, 58, a writer in Los Angeles. "My father died
of heart disease at the age of 42. I was determined
to avoid his fate, so I quit hormone therapy as soon
as I heard about the study’s results."
Without her daily doses of synthetic estrogen and
progestin, Kentz suffered hot flashes that kept her
up nights and mood swings that left her weeping
inconsolably. After a six–month break from
medication, she started using the Femring, a vaginal
ring that releases estrogen and that, taken along
with progestin pills, has helped her feel much
better.
Health advocates say that one–third of the 18
million women who once used hormone therapy are
likely going without treatment or trying alternative
remedies.
First prescribed in the late 1960s, hormone
therapy drugs — either an estrogen-progestin
combination or an estrogen-only version for women
who have had hysterectomies — were touted as the
"cure" for menopause (the stage when women stop
menstruating and estrogen levels drop) and as
protection against heart disease and breast cancer.
Then came the July 2002 publication of landmark
research in the Journal of the American Medical
Association. The federally funded Women’s Health
Initiative study, which enrolled 161,000 women,
found that hormone therapy causes slight increases
in the risk of breast cancer, heart attacks,
strokes, and blood clots and that these risks
outweigh the drugs’ benefits of minor protection
against colorectal cancer and bone fractures.
Thus began a series of blows to hormone therapy’s
reputation. Follow–up studies by Women’s Health
Initiative researchers showed that
estrogen–progestin therapy can increase the risk of
dementia, and that combination and estrogen–only
therapy can cause urinary incontinence. Other
studies showed that combination therapy can boost
the risk of breast and endometrial cancers,
prompting the United Nations’ International Agency
for Research on Cancer to reclassify the medication
as "carcinogenic" instead of "possibly
carcinogenic."
In the wake of these developments, sales of
synthetic hormones plummeted 40 percent, and
alternative remedies began to abound.
Instead of taking conventional hormone therapy,
menopausal women started trying estrogen creams,
gels, and patches that deliver estrogen through the
skin instead of in the pill form studied by the
Women’s Health Initiative. They took serotonin
reuptake inhibitors (anti–depressants including Effexor) to ease hot flashes, and bisphosphonates
(including Fosamax and Actonel) and selective
estrogen receptor modulators (including Evista) to
maintain bone density.
Women also snapped up "bioidentical" hormones
(plant-based estrogens derived from yams and other
natural sources and sold under such names as
Prometrium and TriEst) and health store remedies
including the herbal supplements black cohosh and
phytoestrogens (found in soybeans, legumes, and
whole grains, these mimic human estrogen).
Were these women making the right move? Nearly
four years later, the jury is still out. In
November, the Food and Drug Administration issued
warnings to 16 alternative hormone therapy companies
for marketing unapproved drugs. But some women who
take these remedies swear by them, and there are no
widespread reports of adverse effects.
While the debate on alternative remedies
continues, hormone therapy itself may be making a
comeback. In 2003, separate studies commissioned by
two drug companies found that a quarter of women who
had stopped using conventional hor mone therapy had
since resumed it.
Last year, Wyeth Pharmaceuticals, maker of
Prempro and Premarin (the two drugs used in the
Women’s Health Initiative study) released two low
dose versions of each product with plans to market
several more versions soon.
"Thus far, low-dose hormone therapy appears to be
safe and effective and to relieve symptoms just as
well as older, higher–dose versions," says Dr. Wulf
Utian, director of the North American Menopause
Society.
What’s the upshot for women seeking relief from
the symptoms of menopause?
For now, the Food and Drug Administration
recommends hormone therapy for women at high risk
for the conditions the drugs can treat: hip
fractures and cancer of the bowel or rectum. The FDA
recommends that other women use hormone therapy only
if they are plagued by severe menopausal symptoms
such as mood swings, hot fl ashes, disrupted sleep,
and vaginal dryness, itching, or burning.
Health advocates urge women who are already at
risk for problems associated with hormone therapy
(breast cancer, heart attacks, strokes, and blood
clots) to steer clear of the drugs. They advise all
menopausal women to discuss hormone therapy and
alternative treatments with their doctors, to take
the drugs in the lowest possible dose, and to use
them only as long as symptoms persist.
While authorities continue taking a conservative
approach to alternative treatments, scientists are
beginning to study these remedies’ safety and
efficacy. "We’re hoping that researchers will
develop treatments that work as well as conventional
hormone therapy," says Marilyn Kentz. "We’re hoping
for remedies that can not only ease our symptoms,
but also keep us in good health."
Molly M. Ginty lives in New York. Her work has
appeared in Ms., Marie Claire, Redbook, and Women’s
eNews.
FOR MORE INFORMATION
National Institutes of Health, "Menopausal
Hormone Therapy Information"
www.nih.gov/PHTindex.htm
Our Bodies, Ourselves, "Midlife and Menopause"
www.ourbodiesourselves.org/book/chapter.asp?id=26
North American Menopause Society
www.menopause.org
Article published in Lutheran Woman Today,
July/August 2006
|
We're glad you enjoyed this
online preview of Lutheran Woman Today. But
there is so much more inside each
issue. For just 3 cents a day, you can
receive a year's worth of LWT's
award–winning graphics and articles in your
own home. Don't miss another issue —
Subscribe
now! |
|